Clinical Trials Directory

Trials / Completed

CompletedNCT03518567

Behavioral Economic Analysis of Demand for Marijuana

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
133 (actual)
Sponsor
Brown University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This laboratory study will employ a multi-session experimental design to examine the behavioral economic demand for marijuana, by studying effect of marijuana administration (High THC) on demand for marijuana, and marijuana smoking topography. The study will recruit 100 non-treatment seeking marijuana users who smoke marijuana at least twice weekly.

Detailed description

This laboratory study will employ a multi-session experimental design to examine craving for marijuana, the effect of marijuana administration (High THC) on behavioral economic demand for marijuana, and marijuana smoking topography. The study will recruit 100 non-treatment seeking marijuana users who smoke marijuana at least twice weekly. The relationship between hypothetical and actual demand for marijuana will be examined. We will also investigate relationship between demand for marijuana and indices of marijuana smoking topography. The study will recruit 100 non-treatment seeking marijuana users who smoke marijuana at least twice weekly to obtain a final sample of 85 with complete data (15% of attrition). Participants will be tested at a baseline session and during two experimental sessions (an ad libitum marijuana smoking session and a marijuana smoking topography session). This study will confirm the utility of the hypothetical marijuana purchase task as a reliable and valid tool for assessing behavioral economic marijuana demand.

Conditions

Interventions

TypeNameDescription
DRUGSmoked marijuana cigarettes: High THC dose (6% THC)Smoked marijuana cigarettes (High THC dose \[6% THC\])

Timeline

Start date
2018-10-15
Primary completion
2021-05-24
Completion
2021-05-24
First posted
2018-05-08
Last updated
2024-02-12
Results posted
2024-02-12

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03518567. Inclusion in this directory is not an endorsement.